{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T20:40:07Z","timestamp":1752525607284,"version":"3.41.2"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To evaluate OCT features for vitreomacular traction (VMT) release and change in macular hole (MH) size after treatment with ocriplasmin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients who had undergone treatment with ocriplasmin for VMT with or without MH \u2264400 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m were included. The main outcomes were VMT release and changes in minimum linear diameter MH size at 4 weeks in MHs that persisted. OCT features evaluated were central retinal thickness, vitreomacular adhesion length, posterior vitreous cortex (PVC) insertion angles 500 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m from the insertion points, and minimum linear diameter size.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Sixty patients were included: 37 had isolated VMT and 23 VMT with a MH. Four weeks after ocriplasmin injection, the overall VMT release rate was 66.7% (40\/60); 64.9% (24\/37) in eyes with isolated VMT and 69.6% (16\/23) in eyes with MH. VMT release was associated with younger age (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.02). Macular hole closure was achieved in 26.1% (6\/23) and was associated with a smaller ratio of the temporal to the nasal PVC angle (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.01). Of the 17 persistent MHs, 76.5% (13\/17) increased in minimum linear diameter size from baseline 186 (\u00b178) to 358 (\u00b1133) <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Progression in minimum linear diameter size showed a negative linear association with the size of the nasal PVC angle (R<jats:sup>2<\/jats:sup> = 0.39, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002) and a positive linear association with the ratio of the temporal to nasal PVC angle (R<jats:sup>2<\/jats:sup> = 0.39, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.002).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>In patients with VMT-associated MHs, the risk of MH enlargement following ocriplasmin is negatively correlated with the nasal PVC angle size and is increased if the ratio of the temporal to nasal angle is &gt;1.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004205","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T19:19:37Z","timestamp":1720207177000},"page":"1923-1930","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["OPTICAL COHERENCE TOMOGRAPHY FEATURES ASSOCIATED WITH VITREOMACULAR TRACTION RELEASE AND MACULAR HOLE SIZE PROGRESSION FOLLOWING TREATMENT WITH OCRIPLASMIN"],"prefix":"10.1097","volume":"44","author":[{"given":"Navid","family":"Johannigmann-Malek","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Technical University of Munich (TUM), Hospital rechts der Isar, Munich, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Iannetta","sequence":"additional","affiliation":[{"name":"Sense Organs Department, Sapienza University, Rome, Italy;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yalin","family":"Zheng","sequence":"additional","affiliation":[{"name":"University of Liverpool, Liverpool, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Kaye","sequence":"additional","affiliation":[{"name":"University of Liverpool, Liverpool, United Kingdom; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Groselli","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Technical University of Munich (TUM), Hospital rechts der Isar, Munich, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Kirchmair","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Technical University of Munich (TUM), Hospital rechts der Isar, Munich, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Dervenis","sequence":"additional","affiliation":[{"name":"University of Liverpool, Liverpool, United Kingdom; and"},{"name":"Department of Ophthalmology, University of Thessaly Medical School, Larissa, Greece."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Charbel Issa","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Technical University of Munich (TUM), Hospital rechts der Isar, Munich, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8662-0582","authenticated-orcid":false,"given":"Carmen","family":"Baumann","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Technical University of Munich (TUM), Hospital rechts der Isar, Munich, Germany;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250714","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/eye.2013.212","article-title":"Idiopathic vitreomacular traction and macular hole: a comprehensive review of pathophysiology, diagnosis, and treatment","volume":"27","author":"Steel","year":"2013","journal-title":"Eye (Lond)"},{"key":"R2-20250714","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ajo.2009.11.022","article-title":"Posterior vitreous detachment: evolution and complications of its early stages","volume":"149","author":"Johnson","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"R3-20250714","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1097\/IAE.0b013e3182a6b3e2","article-title":"Pars plana vitrectomy for vitreomacular traction syndrome: a systematic review and metaanalysis of safety and efficacy","volume":"33","author":"Jackson","year":"2013","journal-title":"Retina"},{"key":"R4-20250714","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4103\/jovr.jovr_146_17","article-title":"Pneumatic vitreolysis for management of symptomatic focal vitreomacular traction","volume":"12","author":"Chan","year":"2017","journal-title":"J Ophthalmic Vis Res"},{"key":"R5-20250714","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s00417-022-05568-y","article-title":"Anatomical and functional outcomes of pneumatic vitreolysis for treatment of vitreomacular traction with and without macular holes","volume":"260","author":"Baumann","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R6-20250714","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1056\/NEJMoa1110823","article-title":"Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes","volume":"367","author":"Stalmans","year":"2012","journal-title":"N Engl J Med"},{"key":"R7-20250714","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/j.ophtha.2016.06.043","article-title":"Results of the 2-year ocriplasmin for treatment for symptomatic vitreomacular adhesion including macular hole (OASIS) randomized trial","volume":"123","author":"Dugel","year":"2016","journal-title":"Ophthalmology"},{"key":"R8-20250714","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1097\/IAE.0000000000002332","article-title":"Assessment of anatomical and functional outcomes with ocriplasmin treatment in patients with vitreomacular traction with or without macular holes: results of OVIID-1 trial","volume":"39","author":"Tadayoni","year":"2019","journal-title":"Retina"},{"key":"R9-20250714","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.oret.2018.07.011","article-title":"Ocriplasmin treatment leads to symptomatic vitreomacular adhesion\/vitreomacular traction resolution in the real-world setting: the phase IV ORBIT study","volume":"3","author":"Khanani","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"R10-20250714","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00417-015-3031-1","article-title":"Real-life experience after intravitreal ocriplasmin for vitreomacular traction and macular hole: a spectral-domain optical coherence tomography prospective study","volume":"254","author":"Chatziralli","year":"2016","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R11-20250714","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/IAE.0000000000001371","article-title":"Impact of vitreoretinal interface architecture on successful vitreomacular traction resolution in eyes scheduled for intravitreal ocriplasmin therapy","volume":"37","author":"Paul","year":"2017","journal-title":"Retina"},{"key":"R12-20250714","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1097\/IAE.0000000000003244","article-title":"Revised predictive biomarker for ocriplasmin therapy in vitreomacular traction disorders","volume":"41","author":"Al-Nawaiseh","year":"2021","journal-title":"Retina"},{"key":"R13-20250714","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/IAE.0000000000002862","article-title":"Ocriplasmin for vitreomacular traction in clinical practice: the inject Study","volume":"41","author":"Steel","year":"2021","journal-title":"Retina"},{"key":"R14-20250714","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1167\/iovs.15-16409","article-title":"The plane of vitreoretinal separation and results of vitrectomy surgery in patients given ocriplasmin for idiopathic macular hole","volume":"56","author":"Steel","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R15-20250714","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1097\/IAE.0000000000001473","article-title":"Vitrectomy for persistent macular holes following ocriplasmin injection: a Comparative Multicenter Study","volume":"37","author":"Schumann","year":"2017","journal-title":"Retina"},{"key":"R16-20250714","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.survophthal.2021.08.003","article-title":"Ocriplasmin for treatment of vitreomacular traction and macular hole: a systematic literature review and individual participant data meta-analysis of randomized, controlled, double-masked trials","volume":"67","author":"Jackson","year":"2022","journal-title":"Surv Ophthalmol"},{"key":"R17-20250714","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bjo.2008.153189","article-title":"Predicting visual success in macular hole surgery","volume":"93","author":"Gupta","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R18-20250714","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00417-013-2477-2","article-title":"Idiopathic macular hole: analysis of visual outcomes and the use of indocyanine green or brilliant blue for internal limiting membrane peel","volume":"252","author":"Williamson","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R19-20250714","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41433-020-0844-x","article-title":"Factors affecting anatomical and visual outcome after macular hole surgery: findings from a large prospective UK cohort","volume":"35","author":"Steel","year":"2021","journal-title":"Eye (Lond)"},{"key":"R20-20250714","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1080\/02713683.2019.1708956","article-title":"How big is the hole? Measuring intra- and inter-individual agreement in macular hole size measurements","volume":"45","author":"Antonopoulou","year":"2020","journal-title":"Curr Eye Res"},{"key":"R21-20250714","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.3390\/jcm10132899","article-title":"Repeatability and reproducibility of macular hole size measurements using optical coherence tomography","volume":"10","author":"Baumann","year":"2021","journal-title":"J Clin Med"},{"key":"R22-20250714","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ophtha.2014.07.045","article-title":"Efficacy of intravitreal ocriplasmin for treatment of vitreomacular adhesion: subgroup analyses from two randomized trials","volume":"122","author":"Haller","year":"2015","journal-title":"Ophthalmology"},{"key":"R23-20250714","doi-asserted-by":"crossref","first-page":"759311","DOI":"10.3389\/fmed.2021.759311","article-title":"Efficacy and safety of ocriplasmin use for vitreomacular adhesion and its predictive factors: a systematic review and meta-analysis","volume":"8","author":"Chen","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R24-20250714","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/00055735-199606000-00012","article-title":"Age of onset of posterior vitreous detachment","volume":"7","author":"Yonemoto","year":"1996","journal-title":"Curr Opin Ophthalmol"},{"key":"R25-20250714","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ophtha.2006.08.045","article-title":"Posterior vitreous detachment and retinal detachment after cataract surgery","volume":"114","author":"Ripandelli","year":"2007","journal-title":"Ophthalmology"},{"key":"R26-20250714","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jcrs.2009.02.016","article-title":"Incidence of posterior vitreous detachment after cataract surgery","volume":"35","author":"Mirshahi","year":"2009","journal-title":"J Cataract Refract Surg"},{"key":"R27-20250714","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1038\/eye.2008.273","article-title":"Posterior vitreous detachment following cataract surgery","volume":"23","author":"Hilford","year":"2009","journal-title":"Eye (Lond)"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T20:00:30Z","timestamp":1752523230000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004205","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"type":"print","value":"0275-004X"},{"type":"electronic","value":"1539-2864"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}